Report : North America Radiation Dose Management Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Service/Software (Radiation Dose Management Services and Radiation Dose Management Software), By Medium (Computed Tomography, Radiation and Mammography, Fluoroscopy and Mammography, and Other Medium), and End User (Hospitals, Research and Medical Institutes, and Others)
The Hospitals segment by end user is estimated to lead the market growth during the forecast period.
According to a new market research study of “North America Radiation Dose Management Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Service/Software, Medium, End User and Country.” The North America radiation dose management market is expected to reach US$ 324.67 million by 2028 from US$ 131.35 million in 2021. It is estimated to grow at a CAGR of 13.8% from 2021 to 2028. The report highlights trends prevailing in the North America radiation dose management market and the factors driving market along with those that act as hindrances.
Patients' exposure to radiation has increased significantly over the past two decades. This is due to the increasing number of radiological procedures, such as CT, fluoroscopy, and interventional imaging, and high radiation doses. According to a study by the American Medical Association, the annual increase in CT, MRI, and ultrasound exams was highest between 2000 and 2006. The number increased from 1% to 5% annually between 2012 and 2016 across various age groups. Excess usage of radiation to meet the clinical needs of a procedure may lead to unnecessary radiation exposure. In diagnostic imaging modalities, higher tube currents are generally used for obese patients to improve the image quality.
Due to this, the risk of radiation exposure among obese patients is high. Dose management was never a significant concern for the medical community as their primary focus was to improve image quality (where overexposure yielded better images). Doses of radiation used in procedures have increased, propelling the risk of overexposure to radiation.
Excessive radiation exposure may lead to long-term health consequences. Various concerns have been raised regarding the risks associated with radiation exposure from medical imaging. Additionally, ionizing radiation may damage patients' DNA, and excess exposure may increase the lifetime risk of developing cancer. Millions of exams are performed each year, further making radiation exposure from medical imaging an important public health concern. According to the study, titled understanding the effects of high-dose radiation conducted by the National Institute of Health, it is observed that, in the US, patients are exposed to excessive radiation during brain scans and the dose received is eight times higher than the average level.
Due to rising concerns, the US FDA imposed regulations on imaging centers and manufacturers to follow protocols specific to each scanning procedure. The US FDA also recommends hospitals implement dosing protocols to improve patient safety during CT scans.'
The North America radiation dose management market, by service or software, is segmented into radiation dose management services and radiation dose management software. The North America radiation dose management market, by medium, is segmented into computed tomography, radiation, and mammography, fluroscopy and mammography, and other medium. Based on end user, the North America radiation dose management market is segmented hospitals, research and medical institutes, and others. Geographically, the North America radiation dose management market can be divided into U.S, Canada and Mexico.
FUJIFILM Holdings Corporation, Bayer AG, Bracco Imaging S.p.A, GE Healthcare, Koninklijke Philips N.V., Medsquare, Novarad Corporation, QAELUM INC, Sectra AB and PACSHealth, LLC are among the leading companies operating in the North America radiation dose management market.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com